Research News and Research

RSS

Nominations open for third annual award for ‘Excellence in Science and Medical Journalism’

The Endocrine Society is calling for nominations for the third annual Award for Excellence in Science and Medical Journalism. The award recognizes outstanding reporting that enhances public understanding of health issues pertaining to the field of endocrinology.

12 Jan 2010

More women die of breast cancer in areas where mammography centers are few

More women die of breast cancer in areas where mammography centers are few and far between, according to research by a Medical College of Georgia radiology resident.

12 Jan 2010

U.S. changes HIV policy to allow foreigners with virus to enter

Los Angeles Times: "Last Monday, for the first time in 22 years, foreigners with HIV were legally allowed to enter the United States without their infection status being considered. Before that, even short-term visitors had to receive special permission — or lie on their visa application — to come here.

12 Jan 2010

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

The cardiovascular risk that is associated with proteinuria, or high levels of protein in the urine, a common test used by doctors as an indicator of increased risk for progressive kidney disease, heart attack and stroke, has race-dependent effects, according to a new study by researchers at Wake Forest University School of Medicine.

12 Jan 2010

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

YM BioSciences Inc. today announced results of a collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The approach has successfully concluded its first series of proof-of-principle experiments establishing promise for future development and application.

12 Jan 2010

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.

12 Jan 2010

Flawed medical research could lead to children receiving treatment that either does not work or is harmful

Lisa Hartling, co-director for the University of Alberta's Alberta Research Centre for Health Evidence, looked at 163 North American clinical trials involving children by using a new tool that rates the risk of bias, meaning the benefits and safety of the treatments may have been exaggerated.

12 Jan 2010

Researchers identify genetic variant linked with the risk of prostate cancer

Researchers at Wake Forest University Baptist Medical Center and colleagues have identified the first genetic variant associated with aggressive prostate cancer, proving the concept that genetic information may one day be used in combination with other factors to guide treatment decisions.

12 Jan 2010

University of Haifa receives grant to investigate role of protein expression in memory formation

Prof. Kobi Rosenblum, Head of the Department of Neurobiology and Ethology at the University of Haifa, has been awarded a -1.6 million grant from DIP, a German-Israeli Project Cooperation, over a five-year period. This grant will fund Prof. Rosenblum's international research of the role of protein expression in memory formation and stability.

12 Jan 2010

Detroit paper explores pain of facing breast cancer without insurance

A woman with a $7,000 annual income and $67 in the bank was diagnosed with breast cancer, leading to a week of phone calls from her surgeon to state, federal and hospital officials before a charitable agreement was struck with a medical center, the Detroit Free Press reports.

12 Jan 2010

Jobs numbers in health sector defy recession, more growth expected

As most sectors of the economy shed jobs last month, health care companies continued to defy the pattern and hire more people in a trend that's spanned more than two years, Kaiser Health News reports. The main reason is that people are reluctant to skip health care services, even when times are tight, economists say. That factor, combined with an aging population allowed health care business to grow, albeit more slowly than normal, even as the broader economy flagged (Weaver, 1/8).

12 Jan 2010

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

A leading clinical research center in Austin has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.

12 Jan 2010

Official H1N1-related death count approaches 13,000 worldwide, WHO says

H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).

12 Jan 2010

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Antares Pharma, Inc. and the Population Council today announced successful results from a dose-finding Phase 2 trial for a novel contraceptive gel containing the progestin Nestorone and estradiol (NES/E2) utilizing the Antares ATD (advanced transdermal delivery) gel system. Based on this successful data, the two parties continue to expect to partner with a worldwide or regional pharmaceutical company in order to commercialize this novel contraceptive gel.

12 Jan 2010

Cancer drug may provide an effective secondary treatment for gut tumor

A drug that is already an approved therapy for some cancers also might be an effective secondary treatment for a rare tumor of the gastrointestinal tract, according to a team led by researchers from the University of Pittsburgh Cancer Institute (UPCI). The findings, based on experiments using cell cultures, were published in the Jan. 1 issue of Cancer Research.

12 Jan 2010

AMN Healthcare launches new corporate brand identity

In an effort to more effectively symbolize its position as the leader in the healthcare staffing and management services industry and the unique strength of its interconnecting service offerings, AMN Healthcare announced today that it has launched a new corporate brand identity.

12 Jan 2010

Calif. Gov. Schwarzenegger plans health cuts; news outlets report on Medicaid funding issues

California Gov. Arnold Schwarzenegger is planning cuts to health programs and has "warned more would come if the federal government does not increase program reimbursements," ModernHealthcare reports. "His $82.9 billion spending plan for fiscal 2010-11 includes $750 million in cuts to Medi-Cal, the state's Medicaid program. Prison medical care would be cut by $811 million under his plan." Schwarzenegger is seeking $1.8 billion more in Medicaid funds by raising California's match to the national average for the program — 57 percent (Vesely, 1/8).

12 Jan 2010

Lawmakers, public grapple with health care endgame

Many Democrats consider their health overhaul increasingly politically dicey now, but "are betting that the only thing worse than passing a bill many of them don't like is not passing one at all," the San Francisco Chronicle reports.

12 Jan 2010

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced positive results from a Phase 1 clinical trial of KP106, its novel prodrug for attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, was created using KemPharm’s proprietary Ligand Activated Therapy (LAT) prodrug approach.

12 Jan 2010

New therapeutic treatment may provide a potential alternative to bone grafting operation

A study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.

12 Jan 2010

Research News and Research

Nominations open for third annual award for ‘Excellence in Science and Medical Journalism’

More women die of breast cancer in areas where mammography centers are few

U.S. changes HIV policy to allow foreigners with virus to enter

Proteinuria, a long accepted indicator of heart disease risk, has less impact on African-Americans compared to whites

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

Flawed medical research could lead to children receiving treatment that either does not work or is harmful

Researchers identify genetic variant linked with the risk of prostate cancer

University of Haifa receives grant to investigate role of protein expression in memory formation

Detroit paper explores pain of facing breast cancer without insurance

Jobs numbers in health sector defy recession, more growth expected

Researchers study VA111913 drug as a possible treatment for dysmenorrhea

Official H1N1-related death count approaches 13,000 worldwide, WHO says

Antares Pharma, Population Council report positive Phase 2 results for novel NES/E2 contraceptive gel

Cancer drug may provide an effective secondary treatment for gut tumor

AMN Healthcare launches new corporate brand identity

Calif. Gov. Schwarzenegger plans health cuts; news outlets report on Medicaid funding issues

Lawmakers, public grapple with health care endgame

Positive results from KemPharm's KP106 Phase 1 clinical trial for ADHD

New therapeutic treatment may provide a potential alternative to bone grafting operation

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring